GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » PE Ratio

SeaStar Medical Holding (SeaStar Medical Holding) PE Ratio : At Loss (As of May. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-05-14), SeaStar Medical Holding's share price is $0.3875. SeaStar Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.23. Therefore, SeaStar Medical Holding's PE Ratio for today is At Loss.

SeaStar Medical Holding's EPS (Diluted) for the three months ended in Dec. 2023 was $-0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.23.

As of today (2024-05-14), SeaStar Medical Holding's share price is $0.3875. SeaStar Medical Holding's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.98. Therefore, SeaStar Medical Holding's PE Ratio without NRI ratio for today is At Loss.

SeaStar Medical Holding's EPS without NRI for the three months ended in Dec. 2023 was $-0.17. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.98.

SeaStar Medical Holding's EPS (Basic) for the three months ended in Dec. 2023 was $-0.21. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.23.

Back to Basics: PE Ratio


SeaStar Medical Holding PE Ratio Historical Data

The historical data trend for SeaStar Medical Holding's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SeaStar Medical Holding PE Ratio Chart

SeaStar Medical Holding Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PE Ratio
N/A N/A At Loss At Loss

SeaStar Medical Holding Quarterly Data
Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of SeaStar Medical Holding's PE Ratio

For the Biotechnology subindustry, SeaStar Medical Holding's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SeaStar Medical Holding's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's PE Ratio distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's PE Ratio falls into.



SeaStar Medical Holding PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

SeaStar Medical Holding's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=0.3875/-1.227
=-0.32(At Loss)

SeaStar Medical Holding's Share Price of today is $0.3875.
SeaStar Medical Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.23.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


SeaStar Medical Holding  (NAS:ICU) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


SeaStar Medical Holding PE Ratio Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SeaStar Medical Holding (SeaStar Medical Holding) Business Description

Traded in Other Exchanges
N/A
Address
3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
Executives
Heel Kenneth Van director C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Kevin Chung officer: Chief Medical Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Richard D. Russell director 3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers director 302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron officer: See Remarks C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff director, officer: Chief Executive Officer C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins director C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust 10 percent owner 2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber director 100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc. 10 percent owner 1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson director 400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett director 3929 ARLINGTON DRIVE, PALM HARBOR FL 34685

SeaStar Medical Holding (SeaStar Medical Holding) Headlines

From GuruFocus